Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Research on cancer vaccines published by scientists at University Hospital, Second Department of Internal Medicine
July 29th, 2008
Fresh data on cancer are presented in the report 'Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.' According to a study from Athens, Greece, "Recent years have witnessed the development of a variety of promising immunotherapies for treating patients with B-cell non-Hodgkin's lymphomas. Each B lymphocyte expresses an immunoglobulin molecule that is the product of a unique combination of gene segments." "B cell malignancy arises from one original B lymphocyte, and therefore all the members of a given lymphoma tumor population have the same unique immunoglobulin, which can serve as a target for immune therapy. When the idiotype (Id), or unique...
Source: Cancer Weekly (2008-07-29)
|
